UNC Health Medication Formulary
Add Formweb to your mobile device
UNC Health Medication Formulary
System Formulary Update
Long-Acting Insulin Therapeutic Interchange
Situation
The therapeutic interchange for Long-Acting Insulin was approved for modification at the System Pharmacy and Therapeutics Committee meeting.
Background
The following therapeutic interchange was reviewed: insulin detemir (Levemir), insulin glargine (Toujeo), and insulin degludec (Tresiba)
Assessment/ Recommendations:
System P&T voted to add the following formulary therapeutic interchange for the ordered medication.
|
From |
To |
|
insulin detemir (Levemir), insulin glargine (Toujeo), and insulin degludec (Tresiba) |
Insulin glargine (Lantus) |
Formulary/Epic changes will Go-Live on Tuesday, March 19, 2023.